XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Common stock
IPO
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance (in shares) at Dec. 31, 2018     1,431,305          
Beginning Balance at Dec. 31, 2018 $ 171,020 $ 175 $ 14   $ 157,365 $ (62) $ 13,703 $ 175
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share based compensation 300       300      
Foreign currency translation adjustments (15)         (15)    
Net loss 3,649           3,649  
Ending Balance (in shares) at Sep. 03, 2019     1,431,305          
Ending Balance at Sep. 03, 2019 $ 175,129   $ 14   157,665 (77) 17,527  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting standards update Accounting Standards Update 2014-09 [Member]              
Beginning Balance (in shares) at Dec. 31, 2018     1,431,305          
Beginning Balance at Dec. 31, 2018 $ 171,020 $ 175 $ 14   157,365 (62) 13,703 $ 175
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of vested stock options (in shares) 0              
Ending Balance (in shares) at Dec. 31, 2019     61,321,424          
Ending Balance at Dec. 31, 2019 $ 469,873   $ 613   486,065 21 (16,826)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share based compensation 6,682       6,682      
Foreign currency translation adjustments 57         57    
Net loss (6,462)           (6,462)  
Ending Balance (in shares) at Dec. 31, 2020     61,321,424          
Ending Balance at Dec. 31, 2020 470,150   $ 613   492,747 78 (23,288)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share based compensation 4,380       4,380      
Foreign currency translation adjustments (47)         (47)    
Issuance of common stock to board of director member (in shares)     25,200          
Issuance of common stock to a board of directors member 250       250      
Issuance of common stock (in shares)     8,152 11,666,667        
Issuance of common stock $ 146,136   $ 117   146,019      
Exercise of vested stock options (in shares) 172,728   172,728          
Exercise of vested stock options $ 1,358   $ 2   1,356      
Dividend (74,500)       (74,500)      
Net loss (9,978)           (9,978)  
Ending Balance (in shares) at Dec. 31, 2021     73,194,171          
Ending Balance at Dec. 31, 2021 $ 537,749   $ 732   $ 570,252 $ 31 $ (33,266)